Some lawmakers are urging the Trump administration to rethink a pending rule that may prevent Americans from obtaining medicines from licensed international pharmacies.
The gene-editing company Beam Therapeutics is alleging that one of its scientists stole intellectual property and used it to co-found a Chinese company that made a deal with VC firms.
A new study in mice led by Washington University in St. Louis researchers suggests that stopping certain immune cells from entering the brain could limit neurodegeneration.
UniQure's gene therapy continues to slow Huntington's progression after four years. But the magnitude of the benefit waned compared to a similar analysis from a year ago.
"We should not make families poorer and then punish them for their poverty," write Sandy Santana and Kristen Weber of the National Center for Youth Law.
At a MAHA Institute event, Kennedy and others argued that health data should be more accessible to researchers can study vaccines, chronic diseases, and autism
Late Friday night, the Trump administration clawed back nearly $1 billion in spending approved by Congress, targeting several HHS programs focused on immigrants and diversity
“We’ve come a long way since the fall of 2001, but we find ourselves with recent widening gaps in public health readiness and mitigation,” writes Daniel B. Jernigan.
President Trump is canceling nearly $1 billion in spending approved by Congress, and most of the cuts are focused on HHS programs that serve refugees and unaccompanied minors.
With an eye toward pandemic preparedness, a U.N.-backed agency has signed sub-licensing deals related to generic versions of a Roche influenza treatment.
The FDA approved Eli Lilly’s Onswik, a once-weekly basal insulin for adults with type 2 diabetes, offering patients an alternative to daily long-acting insulin injections.
The Justice Department said in June that it would no longer enforce laws that prioritized people with disabilities living and receiving services in their communities, rather than in nursing homes…
“A discrepancy between how federal and state public health officials determine measles deaths will only increase public confusion,” write Denys T. Lau and Jennifer D. Schoendorf.
Virtually all of the 175,000 public comments on a 2022 FDA proposal to ban menthol cigarettes were form letters, most echoing tobacco industry talking points.
A recent court decision in Indonesia sends an important message to other countries to challenge the pharma industry's use of "patent evergreening," patient advocates say.
Kyverna Therapeutics is one step closer to launching the first cell therapy for an autoimmune disease, with new data in hand showing many patients remained off of other therapies a…
The CDC has added a single measles death to its online counter. In the last few weeks, four unvaccinated people have died from measles in Pennsylvania, according to state officials.…
Gilead Sciences’ top executives have been emphatically bullish about the biotech’s years-long push to develop drugs for inflammatory and autoimmune diseases.
President Trump and his aides boasted that every U.S. state wanted to participate in a drug pricing initiative through Medicaid. Several states said they weren't sure yet.
“The epidemiology and genetics of heart attack and stroke risk, for now, seem to have outpaced what more we can actually do about it,” writes cardiologist Vishal Khetpal.
Biotech investment firm Flagship Pioneering has been awarded a contract by the Department of Defense to advance countermeasure technologies against biological threats.
The chilling effect of the Trump administration's dogged offensive against transgender health care has been swift, with dozens of hospitals across the U.S. ending care, even if they haven't been…
Eli Lilly and Novo Nordisk were already benefitting a great deal from the Trump administration's pilot program covering obesity drugs for seniors at a price of $245 a month. It…
RFK Jr. has installed John Gaitanis, a pediatric neurologist, as the new chair of the Interagency Autism Coordinating Committee, which helps the federal government decide how to allocate roughly $2 billion…
A day after health secretary Robert F. Kennedy Jr. promised that parents concerned about vaccines had a “friend” in the White House, President Trump said he’ll be “demanding” that drug…
"I know what it means to be searching for an explanation to what ails you, and a way to fix it," writes STAT's new trust-in-science reporter, Nicholas Florko.
STAT's Alex Hogan sits down for an in-depth conversation with our new trust-in-science reporter, Nicholas Florko, on the latest episode of STATus Report.
Several Texas hospitals are suing an out-of-state Blue Cross for unpaid medical claims, highlighting the varying standards for whether care is medically necessary.
Amid a civil war in Sudan, it’s now difficult for people with cancer and other long-term illnesses to receive treatment that was once readily available
Health secretary RFK Jr. returned to his roots in a keynote address at a conference hosted by the Children’s Health Defense, an anti-vaccine nonprofit he helped start.
